Karachi, Ferozsons Laboratories Ltd. (FEROZ), a well-established pharmaceutical company, delivered solid financial results. The share rate closed at Rs. 229.35, closely following the daily weighted average of Rs. 229.21. FEROZ, with a paid-up capital of Rs. 434.69 million, announced a 100% cash dividend, a 50% cash dividend, and a 20% bonus distribution. The company’s EPS for January to November 2023 was Rs. 20.02, with a high of Rs. 240.96. Since its listing in 1961, Ferozsons Laboratories has maintained a strong presence in the Pakistan Stock Exchange.
Check Also
Meeting Focuses on Preparations for Youm-e-Istehsal Commemoration
Islamabad: A meeting was held in Islamabad today with Federal Secretary for Kashmir Affairs and Gilgit-Baltistan Kamran Rehman Khan in the chair, to review preparations for the observance of Youm-e-Istehsal on the 5th of next month. According to Rad...
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service